• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 GROSHONG 4F SINGLE-LUMEN PICC (60CM); CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 GROSHONG 4F SINGLE-LUMEN PICC (60CM); CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 11/19/2022
Event Type  Injury  
Manufacturer Narrative
The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) review is not possible, as no manufacturing lot number has been provided by the complainant.
 
Event Description
It was reported on (b)(6) 2022, under the guidance of b-ultrasound, a peripherally intubated central venous catheter was inserted from the basilic vein of the right upper limb into the superior vena cava for intravenous infusion of drugs to prevent extravasation of chemotherapy drugs.After the catheter is inserted, the catheter will be disinfected and changed every week, and the catheter will be flushed and other maintenance.For chemotherapy: from may 26, 2022 to july 29, 2022, 4 cycles of intravenous infusion of cyclophosphamide + doxorubicin + cisplatin chemotherapy will be given for the treatment of thymoma.On (b)(6) 2022, b-ultrasound of the veins of the left upper extremity was performed, indicating that the basilic vein, axillary vein, and subclavian vein indwelling catheters in the right side had undergone intracavitary catheterization, and the basilic vein and axillary vein catheterization had wall thrombosis.On (b)(6) 2022, anticoagulation therapy with low molecular weight heparin calcium 4000iu was started.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GROSHONG 4F SINGLE-LUMEN PICC (60CM)
Type of Device
CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
becky garcia
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key16200232
MDR Text Key307660703
Report Number3006260740-2023-00058
Device Sequence Number1
Product Code LJS
UDI-Device Identifier00801741035326
UDI-Public(01)00801741035326
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K871998
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number7717405
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/30/2022
Initial Date FDA Received01/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-